Standard Chem & Pharm Co Ltd
TWSE:1720
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
58.7
78.7
|
Price Target |
|
We'll email you a reminder when the closing price reaches TWD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Standard Chem & Pharm Co Ltd stock under the Base Case scenario is 91.87 TWD. Compared to the current market price of 65.1 TWD, Standard Chem & Pharm Co Ltd is Undervalued by 29%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Standard Chem & Pharm Co Ltd
Run backtest to discover the historical profit from buying and selling Standard Chem & Pharm Co Ltd based on its intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Price Target |
Loading
|
Revenue Forecast |
|
Operating Income Forecast |
|
Earnings Forecast |
|
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Standard Chem & Pharm Co Ltd
Balance Sheet Decomposition
Standard Chem & Pharm Co Ltd
Current Assets | 5.3B |
Cash & Short-Term Investments | 1.9B |
Receivables | 1.7B |
Other Current Assets | 1.8B |
Non-Current Assets | 6.4B |
Long-Term Investments | 1.6B |
PP&E | 4.4B |
Intangibles | 209.5m |
Other Non-Current Assets | 214.5m |
Current Liabilities | 2.5B |
Accounts Payable | 607.3m |
Short-Term Debt | 319.4m |
Other Current Liabilities | 1.5B |
Non-Current Liabilities | 3.5B |
Long-Term Debt | 408.9m |
Other Non-Current Liabilities | 3.1B |
Earnings Waterfall
Standard Chem & Pharm Co Ltd
Revenue
|
6.6B
TWD
|
Cost of Revenue
|
-3.7B
TWD
|
Gross Profit
|
2.9B
TWD
|
Operating Expenses
|
-1.6B
TWD
|
Operating Income
|
1.3B
TWD
|
Other Expenses
|
-487.6m
TWD
|
Net Income
|
854.1m
TWD
|
Free Cash Flow Analysis
Standard Chem & Pharm Co Ltd
TWD | |
Free Cash Flow | TWD |
Profitability Score
Profitability Due Diligence
Standard Chem & Pharm Co Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Score
Standard Chem & Pharm Co Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Standard Chem & Pharm Co Ltd's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Score
Standard Chem & Pharm Co Ltd's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Standard Chem & Pharm Co Ltd
Shareholder Yield
Current shareholder yield for Standard Chem & Pharm Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Price
Standard Chem & Pharm Co Ltd
Average Annual Return | 21.12% |
Standard Deviation of Annual Returns | 17.87% |
Max Drawdown | -25% |
Market Capitalization | 11.6B TWD |
Shares Outstanding | 178 902 100 |
Percentage of Shares Shorted |
N/A
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Standard Chemical & Pharmaceutical Co., Ltd. engages in the manufacture and sale of Chinese and western medicine, medicine raw materials, and health food. The company is headquartered in Tainan, Tainan. The Company’s products cover drugs for circulation systems, digest systems, respiratory systems, nervous systems and other diseases. Through its subsidiaries, the Company is also engaged in the sales of medical equipment, animal medicine, milk powder, cosmetics and others. The firm distributes its products both in domestic markets and overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Standard Chem & Pharm Co Ltd stock under the Base Case scenario is 91.87 TWD.
Compared to the current market price of 65.1 TWD, Standard Chem & Pharm Co Ltd is Undervalued by 29%.